A new approach to managing intraductal papillary mucinous pancreatic neoplasms.
about
Allogeneic tumor cell vaccines: the promise and limitations in clinical trialsTriphala inhibits both in vitro and in vivo xenograft growth of pancreatic tumor cells by inducing apoptosis.Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer.Immunohistochemical expression of mitochondrial membrane complexes (MMCs) I, III, IV and V in malignant and benign periampullary epithelium: a potential target for drug therapy of periampullary cancer?Epidermal growth factor induces HCCR expression via PI3K/Akt/mTOR signaling in PANC-1 pancreatic cancer cells.Predictive value of tumor proliferative indices in periampullary cancers: Ki-67, mitotic activity index (MI) and volume corrected mitotic index (M/V) using tissue microarrays.Chemoprevention strategies for pancreatic cancerApplying next-generation sequencing to pancreatic cancer treatment.Werner syndrome as a hereditary risk factor for exocrine pancreatic cancer: potential role of WRN in pancreatic tumorigenesis and patient-tailored therapyPancreatic adenocarcinoma up-regulated factor (PAUF) enhances the expression of β-catenin, leading to a rapid proliferation of pancreatic cells.PAUF promotes adhesiveness of pancreatic cancer cells by modulating focal adhesion kinase.Antitumor effect of Kanglaite® injection in human pancreatic cancer xenografts.A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPARC' trial protocol.Parkin deficiency contributes to pancreatic tumorigenesis by inducing spindle multipolarity and misorientation.New treatment options for advanced pancreatic cancer.Sulforaphane potentiates the efficacy of 17-allylamino 17-demethoxygeldanamycin against pancreatic cancer through enhanced abrogation of Hsp90 chaperone function.Silencing of BNIP3 results from promoter methylation by DNA methyltransferase 1 induced by the mitogen-activated protein kinase pathway.Molecular changes in pancreatic cancer.Association of OGG1 Ser326Cys polymorphism and pancreatic cancer susceptibility: evidence from a meta-analysis.Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview.Genomics and pharmacogenomics of pancreatic adenocarcinoma.New biomarkers and targets in pancreatic cancer and their application to treatment.Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration for solid pancreatic lesion: a systematic review.Optimization and preclinical design of genetically engineered viruses for human oncolytic therapy.The impact of vascular resection on early postoperative outcomes after pancreaticoduodenectomy: an analysis of the American College of Surgeons National Surgical Quality Improvement Program database.Hereditary pancreatitis: dilemmas in differential diagnosis and therapeutic approach.Significant association between GSTT1 null genotype and susceptibility to pancreatic cancer.Transcriptional regulatory network and protein-protein interaction to reveal the mechanism of pancreatic cancer.Exosomes: potential for early detection in pancreatic cancer.Hypoxia-induced snail expression through transcriptional regulation by HIF-1α in pancreatic cancer cells.PI3K/AKT/mTOR signaling is involved in (-)-epigallocatechin-3-gallate-induced apoptosis of human pancreatic carcinoma cells.Implantation of radioactive (125)I seeds improves the prognosis of locally advanced pancreatic cancer patients: A retrospective study.A multimodal, one-session endoscopic approach for management of patients with advanced pancreatic cancer.Molecular subtypes in cancers of the gastrointestinal tract.Pancreatic carcinoma cell lines reflect frequency and variability of cancer stem cell markers in clinical tissue.Functional modules analysis based on coexpression network in pancreatic ductal adenocarcinoma.MS analysis reveals O-methylation of L-lactate dehydrogenase from pancreatic ductal adenocarcinoma cells.Endoscopic ultrasound-guided fine needle aspiration of pancreatic masses: the utility and impact on management of patients.Analysis of Endoscopic Radiofrequency Ablation of Biliary Malignant Strictures in Pancreatic Cancer Suggests Potential Survival Benefit.Successful treatment of metastatic pancreatic adenocarcinoma with combination chemotherapy regimens.
P2860
Q26852333-68516BE8-5227-42C1-BA34-C318790D078EQ33375215-59790389-A5C3-4931-B9BC-AF4A04E7DCE9Q33389018-E265723E-8162-4300-8EAF-93B0517B9B27Q33536840-58D60191-2C70-4664-8ED8-D1D204904CE9Q33566269-87AEB8B2-1658-4AF4-814E-E1A579620275Q33607908-B9A64B71-1762-4ACC-975B-5CD3697AA538Q34082960-56E5E741-7FDE-48FF-A9CB-7B169D9DCDA7Q34285351-650DF2A7-A505-4B15-AEF8-F78A7D3FF460Q34582178-812A11F5-7F6A-489B-BE74-1081A30A3C17Q34616999-0E432A59-5ABC-4EC1-95F1-B1FEEBC593CCQ35014211-AB2BEF9D-95C5-4599-9260-F903ACB9837FQ35203429-89567F92-BC81-4BC2-B7BD-52184391DADEQ36130588-80E26948-D514-404B-B6ED-3EE9B2CDEF66Q36823704-49DFED49-AC88-40CE-AF70-A02637863F41Q37345841-CB8D23DB-AF17-4D4D-BC04-786B5C642BCCQ37362480-77182678-80C9-4D71-9BB8-954E93521C54Q37461041-003DC9A8-C539-43EA-8F51-3FF13E80B3BCQ37614592-FFDCFDEB-2EF8-4548-8856-C5156649E185Q37666422-FAB764BF-954C-4969-A74D-88B3877174EEQ37824829-6E8941F4-20DA-41C1-80A2-7F75F7F285BAQ37970279-DB0814D7-77CC-49B5-9B9E-4255ED75282CQ38021692-5C91B5DC-44B9-4E79-BC0C-3B91EB519966Q38023261-C3271A41-DD14-4374-AFA6-46DE02B26ACDQ38025696-90E45F08-0650-40D3-B556-624469DFC341Q38038992-91DEAD4C-ECE6-4AFC-AA3B-A7A900115B05Q38163436-DE8B4BB2-FBC7-4578-AEEB-690417DF6BF2Q38407739-DEB08819-FF7F-4283-9D4C-B67A1026AAA9Q38482432-ECCF9A3A-C9C9-4A82-842D-764E32F4BE45Q38727631-9E8B216F-A110-4308-A72D-DA28E7E5CCC7Q39104655-23DCBFEB-277A-423B-AF8C-63DF7ADAB2D3Q39147023-8B50EE08-9326-4264-82C7-43B013F358A8Q39174079-D39E19AD-98DE-4A0D-82E1-F9787487BABDQ39186045-9522FCC1-A846-4C20-8AF0-D17B08817768Q39235977-F5A68FC5-770C-44A4-A29A-85877CD74721Q39285522-A761626E-3D06-459F-898A-4084F5A8C5C6Q39321919-AF87FC5F-52E6-4AA4-A045-8741E275721DQ39323822-E689F16D-9A37-413D-9857-5E82C7BEB4F2Q39941534-8F95BB6A-E605-4F29-A0E2-259488423F2EQ41698384-B9FD6838-5ACE-4E3A-BC0F-D0F36FC5F2E8Q43255201-9C9AF769-5C9E-4CD3-9175-4BF24A7B9A36
P2860
A new approach to managing intraductal papillary mucinous pancreatic neoplasms.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
A new approach to managing intraductal papillary mucinous pancreatic neoplasms.
@en
A new approach to managing intraductal papillary mucinous pancreatic neoplasms.
@nl
type
label
A new approach to managing intraductal papillary mucinous pancreatic neoplasms.
@en
A new approach to managing intraductal papillary mucinous pancreatic neoplasms.
@nl
prefLabel
A new approach to managing intraductal papillary mucinous pancreatic neoplasms.
@en
A new approach to managing intraductal papillary mucinous pancreatic neoplasms.
@nl
P2860
P356
P1433
P1476
A new approach to managing intraductal papillary mucinous pancreatic neoplasms.
@en
P2093
John Neoptolemos
Paula Ghaneh
P2860
P304
P356
10.1136/GUT.2006.113068
P407
P577
2007-08-01T00:00:00Z